A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF

Journal: Nature Communications

Published: 2021-01-25

DOI: 10.1038/s41467-020-20825-6

Affiliations: 2

Authors: 15

Go to article
Institutions Share
UCB Pharma Limited, United Kingdom (UK) 0.93
UCB Inc., United States of America (USA) 0.07

Return